Danaher Completes Acquisition of Aldevron
Danaher Corporation (NYSE: DHR) has successfully completed its acquisition of Aldevron, which will now function as a standalone entity within Danaher's Life Sciences segment. The acquisition aligns with Danaher's commitment to solving complex challenges in various sectors, including health care. With a diverse team of approximately 69,000 associates, Danaher aims to leverage this acquisition to enhance its operational capabilities and market position.
- Aldevron will enhance Danaher's Life Sciences segment.
- Strategic acquisition supports Danaher's growth in health care and related markets.
- None.
WASHINGTON, Aug. 30, 2021 /PRNewswire/ -- Danaher Corporation (NYSE: DHR) ("Danaher") announced today the completion of its acquisition of Aldevron. As previously announced, Aldevron will operate as a standalone operating company and brand within Danaher's Life Sciences segment.
ABOUT DANAHER
Danaher is a global science and technology innovator committed to helping its customers solve complex challenges and improving quality of life around the world. Its family of world class brands has leadership positions in the demanding and attractive health care, environmental and applied end-markets. With more than 20 operating companies, Danaher's globally diverse team of approximately 69,000 associates is united by a common culture and operating system, the Danaher Business System, and its Shared Purpose, Helping Realize Life's Potential. For more information, please visit www.danaher.com.
View original content:https://www.prnewswire.com/news-releases/danaher-completes-acquisition-of-aldevron-301365300.html
SOURCE Danaher Corporation
FAQ
What is the significance of Danaher's acquisition of Aldevron?
When was the acquisition of Aldevron completed by Danaher?
How will Aldevron operate after the acquisition by Danaher?
What is the stock symbol for Danaher Corporation?
